4//SEC Filing
Pearce Samantha 4
Accession 0001765581-23-000004
CIK 0001232524other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:43 PM ET
Size
8.6 KB
Accession
0001765581-23-000004
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2023-01-03$159.59/sh−531$84,742→ 11,309 total - Exercise/Conversion
Ordinary Shares
2023-01-03$109.45/sh+531$58,118→ 11,840 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-03−531→ 7,438 totalExercise: $109.45Exp: 2030-05-06→ Ordinary Shares (531 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001805688
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:43 PM ET
- Size
- 8.6 KB